These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10484829)

  • 1. Do homeopathic nosodes protect against infection? An experimental test.
    Jonas WB
    Altern Ther Health Med; 1999 Sep; 5(5):36-40. PubMed ID: 10484829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
    Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
    Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
    Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
    Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tularemia: the disease and the weapon.
    Cronquist SD
    Dermatol Clin; 2004 Jul; 22(3):313-20, vi-vii. PubMed ID: 15207312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity.
    Lavine CL; Clinton SR; Angelova-Fischer I; Marion TN; Bina XR; Bina JE; Whitt MA; Miller MA
    Eur J Immunol; 2007 Nov; 37(11):3007-20. PubMed ID: 17960662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
    Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
    Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
    Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
    Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sublethal exposure of European brown hares to paraoxon on the course of tularemia.
    Bandouchova H; Pohanka M; Kral J; Ondracek K; Osickova J; Damkova V; Vitula F; Treml F; Pikula J
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():77-83. PubMed ID: 22167214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against Francisella tularensis.
    Wayne Conlan J; Oyston PC
    Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosafety and selectable markers.
    Titball RW; Sjostedt A; Pavelka MS; Nano FE
    Ann N Y Acad Sci; 2007 Jun; 1105():405-17. PubMed ID: 17416926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the tularemia prevention measures in the natural foci of the Carpathian region].
    Vetchinin VV; Sukhopiatkina AA; Bat OS; Potapova VG
    Vrach Delo; 1980 Jan; (1):107-9. PubMed ID: 7376572
    [No Abstract]   [Full Text] [Related]  

  • 16. The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain.
    Cowley SC; Goldberg MF; Ho JA; Elkins KL
    J Infect Dis; 2008 Jul; 198(2):284-92. PubMed ID: 18593295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Francisella tularensis vaccines.
    Oyston PC
    Vaccine; 2009 Nov; 27 Suppl 4():D48-51. PubMed ID: 19837286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling of Francisella tularensis infected peripheral blood mononuclear cells: a predictive tool for tularemia.
    Paranavitana C; Pittman PR; Velauthapillai M; Zelazowska E; Dasilva L
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):92-103. PubMed ID: 18680519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.